Stahl, SM. Antipsychotic polypharmacy. Part 1: Therapeutic option or dirty little secret?
J Clin Psychiatry
1999; 60: 425–6.
Canales, PL, Olsen, J, Miller, AL, Crismon, ML. The role of antipsychotic polypharmacotherapy in the treatment of schizophrenia. CNS Drugs
1999; 12: 179–88.
Lelliott, P, Paton, C, Harrington, M, Konsolaki, M, Sensky, T, Okocha, C.
The influence of patient variables on polypharmacy and combined high dose of antipsychotic drugs prescribed for in-patients. Psychiatr Bull
2002; 26: 411–4.
Ito, H, Koyama, A, Higuchi, T.
Polypharmacy and excessive dosing: psychiatrists' perceptions of antipsychotic drug prescription. Br J Psychiatry
2005; 187: 243–7.
National Institute for Health and Clinical Excellence. Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care. NICE, 2002.
Royal College of Psychiatrists. Consensus Statement on High Dose Antipsychotic Medication (Council Report CR138). Royal College of Psychiatrists, 2006.
Barbui, C, Nosè, M, Mazzi, MA, Thornicroft, G, Schene, A, Becker, T, et al. Persistence with polypharmacy and excessive dosing in patients with schizophrenia treated in four European countries. Int Clin Pharmacol
2006; 21: 355–62.
Taylor, D, Paton, C, Kerwin, R.
The Maudsley Prescribing Guidelines (8th edn). Taylor & Francis, 2006.
Lieberman, JA, Stroup, TS, McEvoy, JP, Swartz, MS, Rosenheck, RA, Perkins, DO, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med
2005; 353: 1209–23.
Jones, PB, Barnes, TRE, Davies, L, Dunn, G, Lloyd, H, Hayhurst, KP, et al. Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia: cost utility of the latest antipsychotic drugs in schizophrenia study (CUtLASS 1). Arch Gen Psychiatry
2006; 63: 1079–87.
Centorrino, F, Eakin, M, Bahk, W, Kelleher, JP, Goren, J, Salvatore, P, et al. Inpatient antipsychotic drug use in 1998, 1993, and 1989. Am J Psychiatry
2002; 159: 1932–5.
Freudenreich, O, Goff, DC. Antipsychotic combination therapy in schizophrenia. A review of efficacy and risks of current combinations. Acta Psychiatr Scand
2002; 106: 323–30.
Tapp, A, Wood, AE, Secrest, L, Erdmann, J, Cubberley, L, Kilzieh, N.
Combination antipsychotic therapy in clinical practice. Psychiatr Serv
2003; 54: 55–9.
Sernyak, MJ, Rosenheck, R.
Clinicians' reasons for antipsychotic coprescribing. J Clin Psychiatry
2004; 65: 1597–1600.